Parse Biosciences launches Evercode Whole Blood Fixation to enable easy, high-quality single cell RNA-seq from blood.
OrganaBio, LLC, a leading provider of human research- and clinical-grade cellular starting materials and clinical trial support services today announced the opening of its newest cell processing and ...
New fixation method streamlines blood sample handling for translational research SEATTLE--(BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing ...
Background/Introduction: The utility of measuring real-time cellular bioenergetics of peripheral blood mononuclear cells (PBMCs) as biomarkers in disease monitoring, such as the bioenergetic health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback